Sign in
4

Changes in Ownership

PALISADE BIO, INC. Filed Acc 0001493152-26-006831

CEO, CFO sold 3,896 shares at $1.75 ($6,818)

  • CEO, CFO acquired 13,333 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Finley John David CEO, CFO 2026-02-11 Option exercise +13,333 31,249 D: show line 1 in the form
Finley John David CEO, CFO 2026-02-12 Sale −3,896 $1.75 $6,818 27,353 D: show line 2 in the form
Open-market sales · 3,896 sh · avg $1.75 · $6,818

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Finley John David CEO, CFO 2026-02-11 Option exercise · Restricted Stock Units −13,333 26,667 D: show line 3 in the form
Loading xslF345X05/ownership.xml…